Titan Pharmaceuticals (TTNP) Short Interest Ratio & Short Volume

$5.66

+0.10 (+1.80%)

(As of 09/20/2024 ET)

Titan Pharmaceuticals Short Interest Data

Titan Pharmaceuticals (TTNP) has a short interest of 17,100 shares, representing 2.64% of the float (the number of shares available for trading by the public). This marks a 271.74% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 177,008 shares to cover all short positions.

Current Short Interest: 17,100 shares
Previous Short Interest: 4,600 shares
Change Vs. Previous Month: +271.74%
Dollar Volume Sold Short: $104,823.00
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: August 31, 2024

Outstanding Shares: 910,000 shares
Float Size: 648,600 shares
Short Percent of Float: 2.64%
Today's Trading Volume: 2,496 shares
Average Trading Volume: 177,008 shares
Today's Volume Vs. Average: 1%

Short Selling Titan Pharmaceuticals?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Titan Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

TTNP Short Interest Over Time

TTNP Days to Cover Over Time

TTNP Percentage of Float Shorted Over Time

Ad Investors Alley

Forget Trump and Kamala

Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.

Download my Dividend Calendar here

Titan Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/31/2024	17,100 shares	$104,823.00	+271.7%	2.6%	0	$6.13
8/15/2024	4,600 shares	$23,092.00	+2.2%	0.7%	0	$5.02
7/31/2024	4,500 shares	$26,235.00	-48.9%	0.7%	0.7	$5.83
7/15/2024	8,800 shares	$40,920.00	-24.8%	1.4%	1.4	$4.65
6/30/2024	11,700 shares	$65,169.00	+50.0%	1.8%	2.1	$5.57
6/15/2024	7,800 shares	$54,132.00	-4.9%	1.2%	1.1	$6.94
Get the Latest News and Ratings for TTNP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Titan Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/31/2024	8,200 shares	$53,383.64	-13.7%	1.3%	1.3	$6.51
5/15/2024	9,500 shares	$60,800.00	-19.5%	1.5%	1.4	$6.40
4/30/2024	11,800 shares	$79,119.00	+15.7%	2.0%	1.5	$6.71
4/15/2024	10,200 shares	$74,023.44	+161.5%	1.7%	0.9	$7.26
3/31/2024	3,900 shares	$27,924.00	-67.5%	0.6%	0.3	$7.16
3/15/2024	12,000 shares	$112,920.00	-0.8%	2.2%	1.1	$9.41
2/29/2024	12,100 shares	$90,750.00	+10.0%	2.2%	1.4	$7.50
2/15/2024	11,000 shares	$74,800.00	+111.5%	2.0%	1.3	$6.80
1/31/2024	5,200 shares	$29,952.00	+2.0%	1.0%	0.7	$5.76
1/15/2024	5,100 shares	$32,742.00	+15.9%	0.9%	1.1	$6.42
12/31/2023	4,400 shares	$36,300.00	-56.4%	N/A	1.2	$8.25
12/15/2023	10,100 shares	$2,776.49	-87.3%	N/A	0.2	$0.27
11/30/2023	79,400 shares	$27,790.00	-17.5%	N/A	2.1	$0.35
11/15/2023	96,200 shares	$35,594.00	+3.4%	N/A	2.6	$0.37
10/31/2023	93,000 shares	$37,246.50	+49.5%	N/A	2.5	$0.40
10/15/2023	62,200 shares	$28,612.00	-12.4%	N/A	0.7	$0.46
9/30/2023	71,000 shares	$33,654.00	-14.5%	N/A	0.8	$0.47
9/15/2023	83,000 shares	$40,105.60	-6.3%	N/A	0.9	$0.48
8/31/2023	88,600 shares	$45,451.80	-21.9%	N/A	1	$0.51
8/15/2023	113,500 shares	$61,063.00	-68.7%	N/A	1.3	$0.54
7/31/2023	362,200 shares	$222,028.60	+500.7%	N/A	4.3	$0.61
7/15/2023	60,300 shares	$38,531.70	+24.3%	N/A	2.8	$0.64
6/30/2023	48,500 shares	$31,340.70	-1.2%	N/A	2.6	$0.65
6/15/2023	49,100 shares	$36,825.00	No Change	N/A	3.4	$0.75
5/31/2023	49,100 shares	$37,512.40	+6.3%	N/A	3.5	$0.76
5/15/2023	46,200 shares	$34,885.62	-26.1%	N/A	3.1	$0.76
4/30/2023	62,500 shares	$48,731.25	+12.2%	N/A	4	$0.78
4/15/2023	55,700 shares	$44,003.00	+24.1%	N/A	2.4	$0.79
3/31/2023	44,900 shares	$37,267.00	+8.7%	N/A	1.8	$0.83
3/15/2023	41,300 shares	$31,598.63	+4.0%	N/A	1.3	$0.77
2/28/2023	39,700 shares	$37,016.28	-30.0%	N/A	1	$0.93
2/15/2023	56,700 shares	$54,035.10	-28.4%	N/A	1.4	$0.95
1/31/2023	79,200 shares	$80,784.00	-16.3%	N/A	1.9	$1.02
1/15/2023	94,600 shares	$87,296.88	-25.6%	N/A	2.5	$0.92
How the US Will Win the Great Lithium Race (Ad) China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill. Join GM as an early investor in this company by October 3.
12/30/2022	127,200 shares	$99,610.32	-21.0%	N/A	3.7	$0.78
12/15/2022	161,000 shares	$143,290.00	-8.3%	N/A	5.1	$0.89
11/30/2022	175,500 shares	$142,506.00	-22.5%	N/A	5.5	$0.81
11/15/2022	226,300 shares	$217,859.01	+0.7%	N/A	6.5	$0.96
10/31/2022	224,800 shares	$224,800.00	-17.2%	N/A	4.6	$1.00
10/15/2022	271,600 shares	$274,316.00	-11.2%	N/A	4.3	$1.01
9/30/2022	306,000 shares	$330,480.00	-28.5%	N/A	3.6	$1.08
9/15/2022	427,700 shares	$560,287.00	-11.7%	N/A	0.8	$1.31
8/31/2022	484,400 shares	$639,408.00	+7.2%	N/A	0.8	$1.32
8/15/2022	452,000 shares	$687,040.00	-30.1%	N/A	0.7	$1.52
7/31/2022	646,600 shares	$853,512.00	+0.8%	6.7%	0.9	$1.32
7/15/2022	641,800 shares	$782,996.00	+77.2%	6.7%	0.8	$1.22
6/30/2022	362,300 shares	$202,453.24	-9.5%	3.8%	0.5	$0.56
6/15/2022	400,200 shares	$232,116.00	+263.2%	N/A	1.1	$0.58
5/31/2022	110,200 shares	$45,865.24	-40.5%	N/A	0.3	$0.42
5/15/2022	185,300 shares	$104,935.39	-1.6%	N/A	0.7	$0.57
4/30/2022	188,300 shares	$131,245.10	-40.9%	N/A	1.2	$0.70
4/15/2022	318,400 shares	$280,096.48	+15.8%	N/A	1.9	$0.88
3/31/2022	275,000 shares	$263,037.50	+1.1%	N/A	2	$0.96
3/15/2022	272,100 shares	$265,025.40	-17.3%	N/A	0.8	$0.97
2/28/2022	328,900 shares	$335,478.00	-2.9%	N/A	1.1	$1.02
2/15/2022	338,800 shares	$399,784.00	-6.0%	N/A	1.1	$1.18
1/31/2022	360,300 shares	$378,315.00	-9.9%	N/A	1.2	$1.05
1/15/2022	399,700 shares	$403,697.00	-15.5%	N/A	1.1	$1.01
12/31/2021	473,100 shares	$482,562.00	+44.9%	N/A	1.2	$1.02
12/15/2021	326,600 shares	$369,058.00	-3.1%	N/A	0.9	$1.13
11/30/2021	336,900 shares	$485,102.31	-19.7%	N/A	1.8	$1.44
11/15/2021	419,700 shares	$679,914.00	-7.8%	N/A	2.2	$1.62
10/29/2021	455,000 shares	$782,600.00	+20.3%	N/A	2.5	$1.72
10/15/2021	378,200 shares	$673,196.00	+57.3%	N/A	2.1	$1.78
9/30/2021	240,400 shares	$449,548.00	-6.0%	N/A	2.9	$1.87
9/15/2021	255,700 shares	$526,742.00	+39.1%	N/A	2.7	$2.06
8/31/2021	183,800 shares	$411,712.00	-36.3%	1.9%	1.8	$2.24
8/13/2021	288,500 shares	$628,930.00	-18.6%	2.9%	2.7	$2.18
7/30/2021	354,200 shares	$793,408.00	-12.3%	3.6%	3	$2.24
7/15/2021	403,700 shares	$924,473.00	-4.4%	4.1%	2.9	$2.29
6/30/2021	422,400 shares	$1.10 million	-21.1%	4.3%	2.3	$2.60
6/15/2021	535,400 shares	$1.34 million	-21.2%	5.4%	2.5	$2.50
5/28/2021	679,500 shares	$1.66 million	-24.0%	6.9%	2.1	$2.44
5/14/2021	894,200 shares	$2.00 million	-14.8%	9.1%	2	$2.24
4/30/2021	1,050,000 shares	$2.63 million	-13.2%	10.7%	1.1	$2.50
4/15/2021	1,210,000 shares	$2.95 million	-19.3%	12.3%	0.8	$2.44
3/31/2021	1,500,000 shares	$4.28 million	-2.6%	15.2%	0.9	$2.85
3/15/2021	1,540,000 shares	$5.04 million	-2.5%	15.6%	0.9	$3.27
2/26/2021	1,580,000 shares	$5.28 million	+20.6%	16.0%	0.9	$3.34
2/12/2021	1,310,000 shares	$5.02 million	+133.7%	13.3%	0.6	$3.83
1/29/2021	560,500 shares	$1.80 million	+9.9%	5.7%	0.3	$3.22
1/15/2021	509,900 shares	$1.78 million	-15.1%	5.2%	0.3	$3.50
12/31/2020	600,600 shares	$1.95 million	-28.1%	8.5%	0.4	$3.25
12/15/2020	834,700 shares	$2.74 million	-95.0%	11.8%	0.6	$3.28
How the US Will Win the Great Lithium Race (Ad) China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill. Join GM as an early investor in this company by October 3.
11/30/2020	16,600,000 shares	$88.20 million	+61.8%	N/A	11.8	$5.31
11/15/2020	10,260,000 shares	$36.17 million	-30.6%	N/A	0.3	$3.53
10/30/2020	14,790,000 shares	$64.34 million	+133.7%	N/A	0.9	$4.35
10/15/2020	6,330,000 shares	$29.28 million	-1.4%	N/A	1.2	$4.63
9/30/2020	6,420,000 shares	$31.86 million	-5.0%	N/A	1.4	$4.96
9/15/2020	6,760,000 shares	$43.60 million	-3.7%	N/A	1	$6.45
8/31/2020	7,020,000 shares	$48.61 million	+2.2%	N/A	1	$6.92
8/14/2020	6,870,000 shares	$57.71 million	-1.6%	N/A	0.7	$8.40
7/31/2020	6,980,000 shares	$60.94 million	-5.9%	N/A	0.6	$8.73
7/15/2020	7,420,000 shares	$62.33 million	-3.3%	N/A	0.6	$8.40
6/30/2020	7,670,000 shares	$70.46 million	-8.4%	N/A	0.6	$9.19
6/15/2020	8,370,000 shares	$83.26 million	+7.6%	N/A	0.7	$9.95
5/29/2020	7,780,000 shares	$66.12 million	-5.5%	N/A	0.7	$8.50
5/15/2020	8,230,000 shares	$67.90 million	+7.3%	N/A	0.6	$8.25
4/30/2020	7,670,000 shares	$59.48 million	+16.9%	N/A	0.6	$7.76
4/15/2020	6,560,000 shares	$47.04 million	-1.9%	N/A	0.6	$7.17
3/31/2020	6,690,000 shares	$1.61 million	-7.9%	N/A	0.4	$0.24
3/13/2020	7,264,700 shares	$1.60 million	+19.5%	N/A	0.2	$0.22
2/28/2020	6,080,000 shares	$1.40 million	+6.7%	N/A	0.4	$0.23
2/14/2020	5,700,000 shares	$1.37 million	+41.8%	N/A	0.5	$0.24
1/31/2020	4,020,000 shares	$804,000.00	+22.6%	N/A	0.4	$0.20
1/15/2020	3,280,000 shares	$754,400.00	+175.6%	N/A	0.3	$0.23
12/31/2019	1,190,000 shares	$380,800.00	-52.8%	N/A	0.1	$0.32

TTNP Short Interest - Frequently Asked Questions

What is Titan Pharmaceuticals' current short interest?: Short interest is the volume of Titan Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 17,100 shares of TTNP short. 2.64% of Titan Pharmaceuticals' shares are currently sold short. Learn More on Titan Pharmaceuticals' current short interest.
What is a good short interest percentage for Titan Pharmaceuticals?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.64% of Titan Pharmaceuticals' floating shares are currently sold short.
Is Titan Pharmaceuticals' short interest increasing or decreasing?: Titan Pharmaceuticals saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 17,100 shares, an increase of 271.7% from the previous total of 4,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Titan Pharmaceuticals' float size?: Titan Pharmaceuticals currently has issued a total of 910,000 shares. Some of Titan Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Titan Pharmaceuticals currently has a public float of 648,600 shares.

How does Titan Pharmaceuticals' short interest compare to its competitors?: 2.64% of Titan Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Titan Pharmaceuticals: Organovo Holdings, Inc. (0.61%), Microbot Medical Inc. (1.29%), Vincerx Pharma, Inc. (1.34%), Minerva Neurosciences, Inc. (0.20%), MEI Pharma, Inc. (0.18%), TherapeuticsMD, Inc. (0.88%), Chemomab Therapeutics Ltd. (1.78%), MIRA Pharmaceuticals, Inc. (5.96%), Exicure, Inc. (14.43%), Spruce Biosciences, Inc. (0.61%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.
What does it mean to sell short Titan Pharmaceuticals stock?: Short selling TTNP is an investing strategy that aims to generate trading profit from Titan Pharmaceuticals as its price is falling. TTNP shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Titan Pharmaceuticals?: A short squeeze for Titan Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TTNP, which in turn drives the price of the stock up even further.
How often is Titan Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TTNP, twice per month. The most recent reporting period available is August, 31 2024.